# Vaccine and Treatment Evaluation Unit: Pertussis Vaccine Development

> **NIH NIH N01** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2021 · $14,174

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

## Key facts

- **NIH application ID:** 10489227
- **Project number:** 272201300023I-P00005-27200017-1
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Kathryn Margaret Edwards
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $14,174
- **Award type:** —
- **Project period:** 2015-04-07 → 2021-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10489227

## Citation

> US National Institutes of Health, RePORTER application 10489227, Vaccine and Treatment Evaluation Unit: Pertussis Vaccine Development (272201300023I-P00005-27200017-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10489227. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*